abstract |
The present invention relates to novel retinoid-related oropharyngeal receptor gamma (ROR gamma) modulators, methods for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by ROR gamma. |